Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Effect of adeno-associated virus (AAV)-mediated overexpression of PEPCK-M (Pck2) on Clenbuterol-induced muscle growth.

Identifieur interne : 000B52 ( Main/Exploration ); précédent : 000B51; suivant : 000B53

Effect of adeno-associated virus (AAV)-mediated overexpression of PEPCK-M (Pck2) on Clenbuterol-induced muscle growth.

Auteurs : David M. Loczenski-Brown [Royaume-Uni] ; Sarah Jones [Royaume-Uni] ; Jeni Luckett [Royaume-Uni] ; Zoe Daniel [Royaume-Uni] ; Madelaine C. Brearley [Royaume-Uni] ; Francis J P. Ebling [Royaume-Uni] ; Tim Parr [Royaume-Uni] ; John M. Brameld [Royaume-Uni]

Source :

RBID : pubmed:31237922

Descripteurs français

English descriptors

Abstract

We previously identified PEPCK-M (encoded by the Pck2 gene) to be highly up-regulated in skeletal muscle of pigs treated with Ractopamine, an anabolic beta-adrenergic receptor agonist. To determine whether PEPCK-M had a causative role in modulating the skeletal muscle growth response to Ractopamine, we used adeno-associated virus 1 (AAV1) to over-express Pck2 (AAV-Pck2) in murine skeletal muscle. A contralateral limb design was employed, such that each mouse served as its own control (injected with a GFP-only expressing AAV1, labelled AAV-GFP). Daily injections of Clenbuterol (1 mg/kg for 21 days) or vehicle control were also carried out to assess the effects of AAV-Pck2 overexpression on the anabolic response to a beta-adrenergic agonist. AAV-Pck2 overexpression in leg muscles of male C57BL6/J mice for 4 weeks (6-10 weeks of age) increased Pck2 mRNA (~100-fold), protein (not quantifiable) and enzyme activity (~3-fold). There was a trend (p = 0.0798) for AAV-Pck2 overexpression to reduce TA muscle weights, but there was no significant effect on muscle fibre diameters or myosin heavy chain isoform (MyHC) mRNA expression. When skeletal muscle growth was induced by daily administration of Clenbuterol (for 21 days), overexpression of AAV-Pck2 had no effect on the growth response, nor did it alter the expression of Phosphoserine Aminotransferase-1 (Psat1) or Asparagine Synthetase (Asns) mRNA or the Clenbuterol-induced decreases in MyHC IIa and IIx mRNA expression (p = 0.0065 and p = 0.0267 respectively). However AAV-Pck2 overexpression reduced TA muscle weights (p = 0.0434), particularly in the Control (vehicle treated) mice (p = 0.059 for AAV x Clenbuterol interaction) and increased the expression of Seryl-tRNA Synthetase (Sars) mRNA (p = 0.0477). Hence, contrary to the original hypothesis, AAV-Pck2 overexpression reduced TA muscle weights and did not mimic or alter the muscle hypertrophic effects of the beta-adrenergic agonist, Clenbuterol.

DOI: 10.1371/journal.pone.0218970
PubMed: 31237922


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Effect of adeno-associated virus (AAV)-mediated overexpression of PEPCK-M (Pck2) on Clenbuterol-induced muscle growth.</title>
<author>
<name sortKey="Loczenski Brown, David M" sort="Loczenski Brown, David M" uniqKey="Loczenski Brown D" first="David M" last="Loczenski-Brown">David M. Loczenski-Brown</name>
<affiliation wicri:level="4">
<nlm:affiliation>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jones, Sarah" sort="Jones, Sarah" uniqKey="Jones S" first="Sarah" last="Jones">Sarah Jones</name>
<affiliation wicri:level="4">
<nlm:affiliation>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Luckett, Jeni" sort="Luckett, Jeni" uniqKey="Luckett J" first="Jeni" last="Luckett">Jeni Luckett</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Medicine, University of Nottingham Medical School, Nottingham, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Medicine, University of Nottingham Medical School, Nottingham</wicri:regionArea>
<wicri:noRegion>Nottingham</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Daniel, Zoe" sort="Daniel, Zoe" uniqKey="Daniel Z" first="Zoe" last="Daniel">Zoe Daniel</name>
<affiliation wicri:level="4">
<nlm:affiliation>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Brearley, Madelaine C" sort="Brearley, Madelaine C" uniqKey="Brearley M" first="Madelaine C" last="Brearley">Madelaine C. Brearley</name>
<affiliation wicri:level="4">
<nlm:affiliation>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ebling, Francis J P" sort="Ebling, Francis J P" uniqKey="Ebling F" first="Francis J P" last="Ebling">Francis J P. Ebling</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Life Sciences, University of Nottingham Medical School, Nottingham, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Life Sciences, University of Nottingham Medical School, Nottingham</wicri:regionArea>
<wicri:noRegion>Nottingham</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Parr, Tim" sort="Parr, Tim" uniqKey="Parr T" first="Tim" last="Parr">Tim Parr</name>
<affiliation wicri:level="4">
<nlm:affiliation>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Brameld, John M" sort="Brameld, John M" uniqKey="Brameld J" first="John M" last="Brameld">John M. Brameld</name>
<affiliation wicri:level="4">
<nlm:affiliation>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31237922</idno>
<idno type="pmid">31237922</idno>
<idno type="doi">10.1371/journal.pone.0218970</idno>
<idno type="wicri:Area/PubMed/Corpus">000892</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000892</idno>
<idno type="wicri:Area/PubMed/Curation">000892</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000892</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000906</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000906</idno>
<idno type="wicri:Area/Ncbi/Merge">003060</idno>
<idno type="wicri:Area/Ncbi/Curation">003060</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003060</idno>
<idno type="wicri:Area/Main/Merge">000B53</idno>
<idno type="wicri:Area/Main/Curation">000B52</idno>
<idno type="wicri:Area/Main/Exploration">000B52</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Effect of adeno-associated virus (AAV)-mediated overexpression of PEPCK-M (Pck2) on Clenbuterol-induced muscle growth.</title>
<author>
<name sortKey="Loczenski Brown, David M" sort="Loczenski Brown, David M" uniqKey="Loczenski Brown D" first="David M" last="Loczenski-Brown">David M. Loczenski-Brown</name>
<affiliation wicri:level="4">
<nlm:affiliation>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jones, Sarah" sort="Jones, Sarah" uniqKey="Jones S" first="Sarah" last="Jones">Sarah Jones</name>
<affiliation wicri:level="4">
<nlm:affiliation>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Luckett, Jeni" sort="Luckett, Jeni" uniqKey="Luckett J" first="Jeni" last="Luckett">Jeni Luckett</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Medicine, University of Nottingham Medical School, Nottingham, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Medicine, University of Nottingham Medical School, Nottingham</wicri:regionArea>
<wicri:noRegion>Nottingham</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Daniel, Zoe" sort="Daniel, Zoe" uniqKey="Daniel Z" first="Zoe" last="Daniel">Zoe Daniel</name>
<affiliation wicri:level="4">
<nlm:affiliation>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Brearley, Madelaine C" sort="Brearley, Madelaine C" uniqKey="Brearley M" first="Madelaine C" last="Brearley">Madelaine C. Brearley</name>
<affiliation wicri:level="4">
<nlm:affiliation>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ebling, Francis J P" sort="Ebling, Francis J P" uniqKey="Ebling F" first="Francis J P" last="Ebling">Francis J P. Ebling</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Life Sciences, University of Nottingham Medical School, Nottingham, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Life Sciences, University of Nottingham Medical School, Nottingham</wicri:regionArea>
<wicri:noRegion>Nottingham</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Parr, Tim" sort="Parr, Tim" uniqKey="Parr T" first="Tim" last="Parr">Tim Parr</name>
<affiliation wicri:level="4">
<nlm:affiliation>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Brameld, John M" sort="Brameld, John M" uniqKey="Brameld J" first="John M" last="Brameld">John M. Brameld</name>
<affiliation wicri:level="4">
<nlm:affiliation>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adrenergic beta-Agonists (pharmacology)</term>
<term>Animals</term>
<term>Clenbuterol (pharmacology)</term>
<term>Dependovirus (metabolism)</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Muscle Development (drug effects)</term>
<term>Muscle Fibers, Skeletal (drug effects)</term>
<term>Muscle Fibers, Skeletal (metabolism)</term>
<term>Myosin Heavy Chains (drug effects)</term>
<term>Myosin Heavy Chains (metabolism)</term>
<term>Phenethylamines (pharmacology)</term>
<term>Phosphoenolpyruvate Carboxykinase (ATP) (metabolism)</term>
<term>Protein Isoforms (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Agonistes bêta-adrénergiques (pharmacologie)</term>
<term>Animaux</term>
<term>Chaînes lourdes de myosine ()</term>
<term>Chaînes lourdes de myosine (métabolisme)</term>
<term>Clenbutérol (pharmacologie)</term>
<term>Dependovirus (métabolisme)</term>
<term>Développement musculaire ()</term>
<term>Fibres musculaires squelettiques ()</term>
<term>Fibres musculaires squelettiques (métabolisme)</term>
<term>Isoformes de protéines (métabolisme)</term>
<term>Mâle</term>
<term>Phosphoenolpyruvate carboxykinase (ATP) (métabolisme)</term>
<term>Phénéthylamines (pharmacologie)</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en">
<term>Myosin Heavy Chains</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Myosin Heavy Chains</term>
<term>Phosphoenolpyruvate Carboxykinase (ATP)</term>
<term>Protein Isoforms</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Adrenergic beta-Agonists</term>
<term>Clenbuterol</term>
<term>Phenethylamines</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Muscle Development</term>
<term>Muscle Fibers, Skeletal</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Dependovirus</term>
<term>Muscle Fibers, Skeletal</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Chaînes lourdes de myosine</term>
<term>Dependovirus</term>
<term>Fibres musculaires squelettiques</term>
<term>Isoformes de protéines</term>
<term>Phosphoenolpyruvate carboxykinase (ATP)</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Agonistes bêta-adrénergiques</term>
<term>Clenbutérol</term>
<term>Phénéthylamines</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Chaînes lourdes de myosine</term>
<term>Développement musculaire</term>
<term>Fibres musculaires squelettiques</term>
<term>Mâle</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We previously identified PEPCK-M (encoded by the Pck2 gene) to be highly up-regulated in skeletal muscle of pigs treated with Ractopamine, an anabolic beta-adrenergic receptor agonist. To determine whether PEPCK-M had a causative role in modulating the skeletal muscle growth response to Ractopamine, we used adeno-associated virus 1 (AAV1) to over-express Pck2 (AAV-Pck2) in murine skeletal muscle. A contralateral limb design was employed, such that each mouse served as its own control (injected with a GFP-only expressing AAV1, labelled AAV-GFP). Daily injections of Clenbuterol (1 mg/kg for 21 days) or vehicle control were also carried out to assess the effects of AAV-Pck2 overexpression on the anabolic response to a beta-adrenergic agonist. AAV-Pck2 overexpression in leg muscles of male C57BL6/J mice for 4 weeks (6-10 weeks of age) increased Pck2 mRNA (~100-fold), protein (not quantifiable) and enzyme activity (~3-fold). There was a trend (p = 0.0798) for AAV-Pck2 overexpression to reduce TA muscle weights, but there was no significant effect on muscle fibre diameters or myosin heavy chain isoform (MyHC) mRNA expression. When skeletal muscle growth was induced by daily administration of Clenbuterol (for 21 days), overexpression of AAV-Pck2 had no effect on the growth response, nor did it alter the expression of Phosphoserine Aminotransferase-1 (Psat1) or Asparagine Synthetase (Asns) mRNA or the Clenbuterol-induced decreases in MyHC IIa and IIx mRNA expression (p = 0.0065 and p = 0.0267 respectively). However AAV-Pck2 overexpression reduced TA muscle weights (p = 0.0434), particularly in the Control (vehicle treated) mice (p = 0.059 for AAV x Clenbuterol interaction) and increased the expression of Seryl-tRNA Synthetase (Sars) mRNA (p = 0.0477). Hence, contrary to the original hypothesis, AAV-Pck2 overexpression reduced TA muscle weights and did not mimic or alter the muscle hypertrophic effects of the beta-adrenergic agonist, Clenbuterol.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Nottinghamshire</li>
</region>
<settlement>
<li>Nottingham</li>
</settlement>
<orgName>
<li>Université de Nottingham</li>
</orgName>
</list>
<tree>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Loczenski Brown, David M" sort="Loczenski Brown, David M" uniqKey="Loczenski Brown D" first="David M" last="Loczenski-Brown">David M. Loczenski-Brown</name>
</region>
<name sortKey="Brameld, John M" sort="Brameld, John M" uniqKey="Brameld J" first="John M" last="Brameld">John M. Brameld</name>
<name sortKey="Brearley, Madelaine C" sort="Brearley, Madelaine C" uniqKey="Brearley M" first="Madelaine C" last="Brearley">Madelaine C. Brearley</name>
<name sortKey="Daniel, Zoe" sort="Daniel, Zoe" uniqKey="Daniel Z" first="Zoe" last="Daniel">Zoe Daniel</name>
<name sortKey="Ebling, Francis J P" sort="Ebling, Francis J P" uniqKey="Ebling F" first="Francis J P" last="Ebling">Francis J P. Ebling</name>
<name sortKey="Jones, Sarah" sort="Jones, Sarah" uniqKey="Jones S" first="Sarah" last="Jones">Sarah Jones</name>
<name sortKey="Luckett, Jeni" sort="Luckett, Jeni" uniqKey="Luckett J" first="Jeni" last="Luckett">Jeni Luckett</name>
<name sortKey="Parr, Tim" sort="Parr, Tim" uniqKey="Parr T" first="Tim" last="Parr">Tim Parr</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B52 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B52 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31237922
   |texte=   Effect of adeno-associated virus (AAV)-mediated overexpression of PEPCK-M (Pck2) on Clenbuterol-induced muscle growth.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31237922" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021